DRAPER, Utah, Dec. 12, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest health savings account (“HSA”) custodian, invites industry professionals and media to an end of year forum they are sponsoring on "The top 4 employee benefits trends to watch for in 2024."
Scheduled for December 14 at 12 p.m. EST, the Society for Human Resource Management (SHRM) will host the online webinar, which will feature a panel of industry and HealthEquity experts, discussing pivotal trends shaping the benefits landscape in 2024.
The panel will feature Laura Tauber, executive director of self-funded health plans at the University of California, Christy Goldberg-Hirsch, senior vice president of total rewards at RR Donnelley, Steve Neeleman, HealthEquity founder and vice chair, and Cheryl King, HealthEquity chief people officer. They will share diverse perspectives on the following topics:
"These trends are not only shaping the future of employee benefits, but they are also reshaping how we think about work and wellness," said Cheryl King. "This event is an opportunity to better understand these dynamics and prepare for the opportunities and challenges of 2024, which, for many reasons, is going to be an especially pivotal year in our industry."
The webinar will include a 45-minute panel discussion followed by a 15-minute Q&A session, providing attendees with an opportunity to engage directly with these industry leaders and experts. Human Resource (HR) professionals may also apply their webinar attendance to gain credit towards HR certification and recertification requirements.
For more information and to register for the event, please visit SHRM Upcoming Webcasts.
1 (“2023 Annual Healthcare Research FSA & HSA”, Consumer Research study commissioned by Visa and conducted by Material. Nationwide online research conducted in April 2023; FSA survey among 1,200 consumers and HSA survey among 1,032 consumers)
About HealthEquity
HealthEquity and its subsidiaries administer Health Savings Accounts (HSAs) and various other consumer-directed benefits for over 15 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to save lives and empowers consumer healthcare. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our “Purple service” and approach at www.healthequity.com.
Media Contact
Amy Cerny
801-508-3237
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$84.52 |
Daily Change: | 2.03 2.46 |
Daily Volume: | 934,108 |
Market Cap: | US$7.320B |
March 18, 2025 February 18, 2025 January 13, 2025 November 12, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load